FEZOLINETANT - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2023-10-11
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:22:15
Label at a glance#
ProductFEZOLINETANT
Active ingredientFEZOLINETANT
Products#
Every source-derived product name is available through these pages.
- FEZOLINETANT
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FEZOLINETANT | 83VNE45KXX | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VEOZAH | FEZOLINETANT | Astellas Pharma US, Inc. | cae9f798-24f9-4580-a4fc-e6c710cbda3c | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | FEZOLINETANT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.